E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/20/2018 in the Prospect News Structured Products Daily.

New Issue: Credit Suisse sells $2.18 million 8% contingent yield trigger autocalls on CVS

By Susanna Moon

Chicago, March 20 – Credit Suisse AG, London Branch priced $2.18 million of trigger autocallable contingent yield notes due March 5, 2021 linked to CVS Health Corp. stock, according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annual rate of 8% if the stock closes at or above its 66.8% coupon barrier on the observation date for that quarter.

The notes will be called at par if the stock closes at or above its initial level on any quarterly observation date.

The payout at maturity will be par unless the stock finishes below its 66.8% downside threshold, in which case investors will be fully exposed to any losses.

UBS Financial Services Inc. is the distributor.

Issuer:Credit Suisse AG, London Branch
Issue:Trigger autocallable contingent yield notes
Underlying stock:CVS Health Corp. (Symbol: CVS)
Amount:$2,175,670
Maturity:March 5, 2021
Contingent coupon:8%, payable quarterly if stock closes at or above 66.8% coupon barrier on observation date for that quarter
Price:Par of $10
Payout at maturity:Par unless stock finishes below downside threshold, in which case 1% loss for each 1% decline
Call:At par if stock closes at or above initial level on any quarterly observation date after six months
Initial price:$67.46
Downside threshold:$45.06, 66.8% of initial price
Pricing date:March 2
Settlement date:March 7
Agent:UBS Financial Services Inc.
Fees:2%
Cusip:22549E648

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.